JAZZ Jazz Pharmaceuticals plc
Price Chart
Executive Summary
Jazz Pharmaceuticals filed a DEFA14A, which is additional definitive proxy soliciting material, filed as an amendment or supplement to the proxy statement. The filing appears to be related to the 2026 annual meeting notice, following a recent announcement that director Anne O'Riordan will not stand for re-election. No substantive financial or strategic details are present in the filing documents.
Actionable Insight
Monitor for any definitive proxy statement or activist response ahead of the annual meeting. The departure of a director near the AGM could signal board refreshment or be related to ongoing governance discussions.
Key Facts
- Filed as DEFA14A (additional definitive proxy soliciting materials)
- Relates to the 2026 annual meeting of shareholders
- Filed 10 days after an 8-K (5.02) disclosing a director will not stand for re-election
- Director Anne O'Riordan's decision was not due to any dispute with the company
Financial Impact
Not specified
Risk Factors
- Potential for proxy fight or activist campaign if further board changes emerge
- Director departure may reduce board diversity or specific expertise
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001232524-26-000030 |
| Document: 0001232524-26-000030-index-headers.html | 0001232524-26-000030 |
| Document: 0001232524-26-000030-index.html | 0001232524-26-000030 |
| Document: 0001232524-26-000030.txt | 0001232524-26-000030 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
1d ago
|
DEFA14A
| $231.98 awaiting T+1 | awaiting T+1 | — | $232.04 (+0.03%) |
|
Jun 3, 2026
6d ago
|
Insider Cluster
| $239.17 $238.57 | ▲ +0.25% | ▼ −2.32% | $232.04 (+2.98%) |
|
Jun 3, 2026
6d ago
|
Insider Cluster
| $240.06 $238.57 | ▼ −0.62% | ▲ +1.98% | $232.04 (−3.34%) |
|
Jun 1, 2026
8d ago
|
144
| $226.12 $230.93 | ▲ +2.13% | ▲ +2.85% | $232.04 (+2.62%) |
|
May 29, 2026
11d ago
|
8-K
| $231.19 $226.12 | ▼ −2.19% | ▼ −2.34% | $232.04 (+0.37%) |
|
May 1, 2026
5w ago
|
144
| $202.51 $207.89 | ▲ +2.66% | ▲ +3.00% | $232.04 (+14.58%) |
|
Apr 24, 2026
6w ago
|
10-K/A
| $200.31 $203.07 | ▲ +1.38% | ▲ +1.86% | $232.04 (+15.84%) |
|
Apr 1, 2026
9w ago
|
144
| $186.73 $185.83 | ▼ −0.48% | ▼ −0.96% | $232.04 (+24.26%) |
|
Feb 27, 2026
14w ago
|
Insider Cluster
| $189.00 $190.30 | ▲ +0.69% | ▲ +0.63% | $232.04 (+22.77%) |
|
Feb 27, 2026
14w ago
|
Insider Cluster
| $189.00 $190.30 | ▲ +0.69% | ▲ +0.63% | $232.04 (+22.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access